Major Investor Quietly Ramps Up Stake in Sol-Gel Technologies
TipRanks (Fri, 22-May 10:09 PM ET)
Sol-Gel Technologies Ltd. Announces Pricing of Oversubscribed Underwritten Offering
Globe Newswire (Mon, 23-Mar 9:38 PM ET)
Sol-Gel Files Annual Report on Form 20-F for the Year Ended December 31, 2025
Globe Newswire (Thu, 19-Mar 8:53 AM ET)
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted. It generates the majority of its revenue from the United States.
Sol-Gel Technologies Ltd. - trades on the NASDAQ stock market under the symbol SLGL.
As of May 22, 2026, SLGL stock price climbed to $76.73 with 76,815 million shares trading.
SLGL has a beta of 0.32, meaning it tends to be less sensitive to market movements. SLGL has a correlation of 0.00 to the broad based SPY ETF.
SLGL has a market cap of $249.01 million. This is considered a Small Cap stock.
Last quarter Sol-Gel Technologies Ltd. - reported $696,000 in Revenue and -$1.06 earnings per share. This fell short of revenue expectation by $-6 million and missed earnings estimates by -$1.45.
In the last 3 years, SLGL traded as high as $97.97 and as low as $3.34.
SLGL has outperformed the market in the last year with a price return of +898.4% while the SPY ETF gained +29.1%. However, in the short term, SLGL had mixed performance relative to the market. It has underperformed in the last 3 months, returning -8.6% vs +8.4% return in SPY. But in the last 2 weeks, SLGL shares have fared better than the market returning +8.3% compared to SPY +1.1%.
SLGL support price is $62.66 and resistance is $73.96 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SLGL shares will trade within this expected range on the day.
